Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 16473 | 587 | 51.5 | 92% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 348 | 16958 | DNA METHYLATION//EPIGENETICS//HISTONE DEACETYLASE INHIBITOR |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC | Address | 6 | 100% | 1% | 4 |
| 2 | HUNAN MED EPIGEN | Address | 4 | 36% | 2% | 9 |
| 3 | TOLERANCE BREAKDOWN | Author keyword | 4 | 46% | 1% | 6 |
| 4 | SURG TRAUMA EMERGENCY SURG SURG CRIT C | Address | 3 | 39% | 1% | 7 |
| 5 | TRAUMA EMERGENCY SURG SURG CRIT CARE | Address | 3 | 12% | 4% | 24 |
| 6 | EXPT HTS | Address | 3 | 60% | 1% | 3 |
| 7 | CHROMATIN DIS GRP | Address | 2 | 24% | 1% | 8 |
| 8 | JOHN HOPKINS AUTOIMMUNE DIS | Address | 2 | 67% | 0% | 2 |
| 9 | LUPUS T CELLS | Author keyword | 2 | 67% | 0% | 2 |
| 10 | IL RISK ASSESSMENT INTERVENT STUDIES | Address | 2 | 27% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CARDIAC HISTONES | 48 | 100% | 3% | 17 |
| 2 | DNA METHYLATION INHIBITORS | 29 | 75% | 4% | 21 |
| 3 | SYNGENEIC MICE | 26 | 54% | 6% | 33 |
| 4 | MRL LPR LPR MOUSE | 15 | 63% | 3% | 15 |
| 5 | DRUG INDUCED LUPUS | 12 | 22% | 8% | 49 |
| 6 | RESUSCITATION STRATEGIES | 11 | 78% | 1% | 7 |
| 7 | ARTHRITIS SYNOVIAL FIBROBLASTS | 5 | 25% | 3% | 16 |
| 8 | ABNORMAL DNA METHYLATION | 4 | 67% | 1% | 4 |
| 9 | CELL DNA METHYLATION | 4 | 33% | 2% | 9 |
| 10 | PHARMACOLOGICAL RESUSCITATION | 3 | 100% | 1% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Impaired DNA methylation and its mechanisms in CD4(+)T cells of systemic lupus erythematosus | 2013 | 40 | 95 | 42% |
| Epigenetic control of autoimmune diseases: From bench to bedside | 2015 | 3 | 134 | 30% |
| Epigenetic dysregulation in systemic lupus erythematosus | 2014 | 11 | 65 | 43% |
| The critical importance of epigenetics in autoimmunity | 2013 | 41 | 100 | 33% |
| Epigenetics and lupus | 2015 | 1 | 30 | 53% |
| Epigenetic modifications in rheumatoid arthritis, a review | 2013 | 12 | 36 | 61% |
| Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? | 2015 | 1 | 119 | 44% |
| Epigenomics of autoimmune diseases | 2015 | 2 | 77 | 25% |
| The epigenetic face of systemic lupus erythematosus | 2006 | 103 | 39 | 41% |
| Epigenetic alterations in autoimmune rheumatic diseases | 2011 | 67 | 85 | 27% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | TRAUMA EMERGENCY SURG SURG CRIT CAREMASSAC | 6 | 100% | 0.7% | 4 |
| 2 | HUNAN MED EPIGEN | 4 | 36% | 1.5% | 9 |
| 3 | SURG TRAUMA EMERGENCY SURG SURG CRIT C | 3 | 39% | 1.2% | 7 |
| 4 | TRAUMA EMERGENCY SURG SURG CRIT CARE | 3 | 12% | 4.1% | 24 |
| 5 | EXPT HTS | 3 | 60% | 0.5% | 3 |
| 6 | CHROMATIN DIS GRP | 2 | 24% | 1.4% | 8 |
| 7 | JOHN HOPKINS AUTOIMMUNE DIS | 2 | 67% | 0.3% | 2 |
| 8 | IL RISK ASSESSMENT INTERVENT STUDIES | 2 | 27% | 1.2% | 7 |
| 9 | HUNAN MED EPIGENOM | 2 | 33% | 0.7% | 4 |
| 10 | CANC 5310 | 1 | 100% | 0.3% | 2 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000125666 | HISTONE DEACETYLASE INHIBITOR//HISTONE DEACETYLASE INHIBITORS//HISTONE DEACETYLASE |
| 2 | 0.0000085436 | METABOLIC MEMORY//HYPERGLYCEMIC MEMORY//EPIGEN PROFILING IL |
| 3 | 0.0000084015 | CELLULAR INJURY//TCR ZETA CHAIN//CD3 GAMMA |
| 4 | 0.0000082554 | EPIGENETIC EPIDEMIOLOGY//EWAS//EPIGENETICS |
| 5 | 0.0000080422 | DNMT3B//DNA METHYLTRANSFERASE//DNMT1 |
| 6 | 0.0000076385 | MIR 155//MIR 146A//MIRNA 155 |
| 7 | 0.0000072986 | PROPYLTHIOURACIL//BENZYLTHIOURACIL//DRUG INDUCED LUPUS |
| 8 | 0.0000068538 | MEF2C//MEF2//MEF2D |
| 9 | 0.0000065889 | FIBROBLAST LIKE SYNOVIOCYTES//BEREICH MOL MED MUSKULOSKELETALEN SYST//ABORATING MOL BIOL NOVEL THER EUT STRA |
| 10 | 0.0000062525 | PTPN22//PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22//IRF5 |